ASP Isotopes (ASPI) Tuesday morning said it has started production of commercial samples of Ytterbium-176 after recently completing construction and commissioning the laser system at its first quantum enrichment facility in Pretoria, South Africa.
Ytterbium-176 is a stable isotope of the rare earth element ytterbium, which is used in the production of Lutetium-177, a radiopharmaceutical used to treat various types of cancer, the company said.
ASP said it expects commercial sale of "highly enriched" Ytterbium-176 within this year.
Shares of the company rose 1.4% in recent trading.
Price: 4.76, Change: +0.06, Percent Change: +1.39
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.